The parenteral packaging market was valued at USD 1146 Million in 2021, and it is expected to reach USD 24,973 Million in 2028 with a CAGR of 5.5 % during the forecast period of 2022-2028. Packaging is the main part of the product. Packaging in pharmaceuticals is critical to drug stability. The packaging of pharmaceuticals protects the product from various factors such as moisture, sunlight, and other environmental factors. It, in turn, inhibits microbial development and expands the shelf life of the drug. Parental medicines are dispensed in the body other than oral or rectal. Shared parental drug administration sites are intravenous, intramuscular, or subcutaneous. The parental drug directly administered in the body should be sterile and particle-free, so packaging plays an important role in the parental drugs.
Parenteral packaging is the packaging of sterile outputs created by utilizing one or more additional than one chemical element, which is operated specifically for the packaging of different medicinal liquids utilized in injections and infusions to treat different chronic diseases. The parenteral packaging is accomplished into two dosage types: single and multiple dosages.
The parenteral industry is growing at a rapid pace in emerging economies. Advanced manufacturing methods, technological innovations, and improved integration of organizations have resulted in the industry’s rapid.
Growth. This development of the pharmaceutical industry is pushing the parental packaging market. The growth is expected to be the highest in emerging economies like Brazil, Russia, India, and China. Rising income levels and growing attention to the benefits of good healthcare systems and healthier lifestyles support these countries’ growth. Large population and demographic factors such as the growing young population and higher life expectancy are also the key drivers of this growth.
An expansion in the aging population and the rising incidence of lifestyle conditions such as diabetes and hypertension has shown an expansion in the utilization of parenteral drugs in both formed and occurring economies. As per the U.S. population Bureau, the aging population was around 50,683,620 in 2016 and is expected to reach 71,453,471 by 2030. The increased prevalence of Alzheimer’s disease and the aging population around the globe are anticipated to select the growth of the parenteral packaging market. According to the World Health Organization, the AD claims worldwide were around 47 million and will reach around 75 million by 2030. the number of patients is forecasted to triple by 2050 due to the high majority rate and shortage of healthcare benefits in rural areas.
It Executes stringent restrictions and measures for operating pharmaceutical-grade materials, including glass and plastic. For instance, the World Health Organization (WHO) has developed policies on the packaging of pharmaceutical products, which require to be followed by pharmaceutical associations. Growth in the geriatric population and the rising incidence of lifestyle diseases such as diabetes and hypertension have increased the utilization of parenteral drugs in both developed and emerging economies.
Imitation drugs are created with inaccurate components in improper quantities, which, when consumed, would result in harmful influences such as allergic reactions or sometimes death. Almost half of the imitation drugs are reported in growing economies like China, the Philippines, and Vietnam. Delay in support of new drugs, and they are parental.
Packaging due to the extended product development processes and expenditures results in the improved availability of imitation drugs and faked packaging. These imitation products negatively affect the human body concerning allergic reactions, nausea, vomiting, etc. Defending against these imitation products is a significant challenge for the sector.
Before the covid-19 outbreak, the growth of prefilled syringes will be a driver for the parenteral packaging market in the forecast period. Chemical avoidance of the internal character of glass tubing containers is anticipated to restrain the parenteral packaging market in the forecast period. Implementing ready-to-use glass vials for flexible aseptic filling brings new avenues for the parenteral packaging market. Recycling waste delivered by pharmaceutical packaging is inquiring the parenteral packaging market.
During the Covid-19, the pandemic had negative impacts on the healthcare industry. Deficiency of infrastructure, manpower, disturbances in the supply chain, absence of preparedness, deficiency of important drugs, and many different elements were accountable for the reduction in healthcare industry functioning. The procedures were not vigorous enough to handle such disruptions in the supply chain, infrastructure, manpower, etc. China, a major import destination of medical equipment, healthcare supply chain requirements, and drug formulations, was reeling under the pandemic. It has resulted in the loss of stability in both the healthcare and pharmaceutical sectors. The global medical supply chain is still imbalanced but stabilizes as per the new normal.
After the covid-19, Packaging movements were supposed to be necessary during the pandemic. Pharmaceutical packaging businesses profited from this and shared stable revenue growth in 2021. Pharmaceutical packaging companies had improved their productivity to sustain the increased demand for blister packs, vials, prefilled syringes, containers, bottles, cartridges, and pouches. It was largely due to an improved market for Covid-19 related medicines and vaccines. In development, parental packaging for biologics, smart packaging, sterile packaging, patient emphasis packaging, cleanroom expansion, and others would push the market long-term.
Based on Product type segmental analysis, the market is classified into Bags, Bottles, Ampoules, Vials, Prefilled Syringes and Cartridges. Bottles reached the largest market share amongst other types in the parenteral packaging market. Bottles are the multiple used types of packaging operated for pharmaceutical products. Bottles are appropriate for holding drugs in liquid and solid forms and can be coupled with the necessary cap & closure to suit specific applications such as nasal spray and ophthalmic drops.
The market is classified into Glass, Polymer, PVC and Polyolefin. Glass packing has the highest share in the market. They are utilized as packaging material for parenteral products or powders for parenteral use ONLY where suitable stability test data indicates that glass is satisfactory. It is also operated in packaging non-parenteral preparations.
Based on the regional segmental analysis, the market is classified into North America, Europe, Asia-Pacific, South America and The Middle East & Africa. Asia-Pacific monopolizes the parenteral packaging market as in China, the exhibition and consumption of parenteral packaging are growing for the single dosage segment in the region. The Asia-Pacific area is predicted to increase with the highest growth rate in the forecast period of 2022 to 2028 because of increased inventions and expansion in manufacturing products for the single dosage segment, which is one of the significant elements for the development of the parenteral packaging market. Germany is showing the growth of the European parenteral packaging market due to increased health awareness among consumers. The U.S. dominates the North American parenteral packaging market due to more demand for parenteral packaging for the single dosage segment because of shelf-life improvement properties, which has widened its consumption.
The companies include Becton, Dickson and Company, Amcor, Daibochi Plastic, Charter Nex Films, Catalent Inc., Celplast Metalized Products, UDG Healthcare Plc, Prairie State Group, Gerresheimer AG, Schur Flexibles Group and other prominent players in the global parenteral packaging market.
Key Stakeholders
| Report Attribute | Details |
|---|---|
| Market Size Value in 2021 | USD 1146 Million |
| The revenue forecast in 2028 | USD 24,973 Million |
| Growth Rate | CAGR of 5.5 % from 2022 to 2028. |
| Historical data | 2017 – 2020 |
| Forecast period | 2022 – 2028 |
| Region covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Key companies Profiled | The companies include Becton, Dickson and Company, Amcor, Daibochi Plastic, Charter Nex Films, Catalent Inc., Celplast Metalized Products, UDG Healthcare Plc, Prairie State Group, Gerresheimer AG, and Schur Flexibles Group are the key players. |
By Product Type
By Material
By region
The growth estimates for parenteral packaging are USD 24,973 Million by 2028.
The companies include Becton, Dickson and Company, Amcor, Daibochi Plastic, Charter Nex Films, Catalent Inc., Celplast Metalized Products, UDG Healthcare Plc, Prairie State Group, Gerresheimer AG, Schur Flexibles Group and other prominent players in the global parenteral packaging market.
Bottles reached the largest market share amongst other types in the parenteral packaging market. Bottles are the multiple used types of packaging operated for pharmaceutical products.
The increasing number of surgical procedures and chronic disease cases such as diabetes and cancer are major factors that are anticipated to propel the market’s development over the forecast period.
North America holds dominates the global parenteral packaging market.
Analyst support
After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.
Customer satisfaction
According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.
Inimitable expertise
Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.
Assured quality
We have created a systematic way to determine standards and satisfy your expectations.
Instant delivery
Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.
Privacy policy
We understand the inkling of your privacy, we will never misuse your email address.
Custom research service
We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.
Quality & accuracy
We provide you with the accurate quality of the customized study of an exclusive report according to your research need.
Data visualization
As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.
Information security
We truly respect your privacy and promise to keep your personal and confidential information safe and secure.